• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13D/A filed by Bioceres Crop Solutions Corp.

    10/1/25 6:05:27 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials
    Get the next $BIOX alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)


    Bioceres Crop Solutions Corp.

    (Name of Issuer)


    Ordinary Shares, par value $0.0001

    (Title of Class of Securities)


    G1117K114

    (CUSIP Number)


    Noah Kolatch
    930 Sylvan Avenue, Suite 140
    Englewood Cliffs, NJ, 07632
    (786) 688-2201


    Greg Kramer
    30 Rockefeller Plaza, 26th Floor
    New York, NY, 10112
    (212) 835-4819

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
    09/30/2025

    (Date of Event Which Requires Filing of This Statement)


    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






    SCHEDULE 13D

    CUSIP No.
    G1117K114


    1 Name of reporting person

    Jasper Lake Ventures One LLC
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    WC
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    7,482,961.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    7,482,961.00
    11Aggregate amount beneficially owned by each reporting person

    7,482,961.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    10.7 %
    14Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:
    The number of shares in rows 8, 10 and 11 consists of 397,000 Ordinary Shares held by Jasper Lake as of the filing of this Schedule 13D plus the Ordinary Shares issuable upon the conversion of the Notes held by Jasper Lake. The percentage set forth in Row 13 is calculated based on (i) 62,712,602 Ordinary Shares of the Issuer outstanding as of March 31, 2025, as reported in the Issuer's current report on Form 6-K filed with the Commission on June 20, 2025, plus (ii) 7,085,961 Ordinary Shares issuable upon the conversion of the Note, which is convertible within 60 days of this Schedule 13D.


    SCHEDULE 13D

    CUSIP No.
    G1117K114


    1 Name of reporting person

    Noah Kolatch
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    OO
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    7,482,961.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    7,482,961.00
    11Aggregate amount beneficially owned by each reporting person

    7,482,961.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    10.7 %
    14Type of Reporting Person (See Instructions)

    IN, HC

    Comment for Type of Reporting Person:
    The number of shares in Rows 8, 10 and 11 consists of 397,000 Ordinary Shares held by Jasper Lake as of the filing of this Schedule 13D plus the Ordinary Shares issuable upon the conversion of the Notes held by Jasper Lake. The percentage set forth in Row 13 is calculated based on (i) 62,712,602 Ordinary Shares of the Issuer outstanding as March 31, 2025, as reported in the Issuer's current report on Form 6-K filed with the Commission on June 20, 2025, plus (ii) 7,085,961 Ordinary Shares issuable upon the conversion of the Notes, which is convertible within 60 days of this Schedule 13D.


    SCHEDULE 13D

    Item 1.Security and Issuer
    (a)Title of Class of Securities:

    Ordinary Shares, par value $0.0001
    (b)Name of Issuer:

    Bioceres Crop Solutions Corp.
    (c)Address of Issuer's Principal Executive Offices:

    Ocampo 210 bis, Predio CCT, Rosario, ARGENTINA , 2000.
    Item 1 Comment:
    Item 1 of the Schedule 13D is hereby amended and supplemented as follows: This Amendment No. 1 to Schedule 13D (this "Amendment") is being filed by the undersigned, pursuant to ss.240.13d-2(a), to amend and supplement the Schedule 13D filed with the U.S. Securities and Exchange Commission (the "SEC") on August 8, 2025 (as amended, the "Schedule 13D"), with respect to the ordinary shares, $0.0001 par value (the "Ordinary Shares"), of Bioceres Crop Solutions, Corp. (the "Issuer"). Except as specifically provided herein, this Amendment does not modify any of the information previously reported in the Schedule 13D. Capitalized terms used but not defined in this Amendment shall have the meanings given to them in the Schedule 13D.
    Item 2.Identity and Background
    (c)
    Item 2(c) of the Schedule 13D is hereby amended and restated in its entirety as follows: Jasper Lake is principally engaged in investing. Noah Kolatch is a principal of Jasper Lake. As a result, Mr. Kolatch may be deemed to share voting and dispositive power with respect to the securities of Issuer held by Jasper Lake. Voting and investment decisions with respect to securities held by Jasper Lake are made by the managers of Jasper Lake. Each of the Reporting Persons may also serve as general partner, principal or manager of certain other entities engaged in the purchasing, holding, and selling of securities for investment purposes.
    Item 4.Purpose of Transaction
     
    Item 4 of the Schedule 13D is hereby amended and supplemented as follows: On September 25, 2025, Jasper Lake, through counsel, delivered a reservation of rights letter to the Issuer, which, among other things, notified the Issuer that certain Events of Default have occurred and are continuing under the Note Purchase Agreement and informed the Issuer that the Jasper Lake reserves all rights and remedies available to it under the Note Purchase Agreement and applicable law. The Issuer has responded and disputes that any such Events of Default have occurred under the Note Purchase Agreement. In connection with the delivery of the reservation of rights of letter, Mr. Kolatch resigned from his position as a member of the Board of the Issuer effective September 30, 2025.
    Item 5.Interest in Securities of the Issuer
    (a)
    Each Reporting Person may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for the purposes of Section 13(d) or 13(g) of the Act. Each Reporting Person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, (i) acting (or has agreed or is agreeing to act) with any other person as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring holding, or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer or (ii) a member of any syndicate or group with respect to the Issuer or any securities of the Issuer. Items 7 through 11 and 13 of each of the cover pages of this Amendment are incorporated herein by reference. The percentages set forth herein are calculated based on (i) 62,712,602 Ordinary Shares of Bioceres Crop Solutions Corp. (the "Issuer") outstanding as March 31, 2025, as reported in the Issuer's current report on Form 6-K filed with the U.S. Securities and Exchange Commission (the "Commission") on June 20, 2025, plus (ii) 7,085,961 Ordinary Shares that the Reporting Persons currently have the right to acquire within 60 days upon conversion of the Notes.
    (b)
    As of September 30, 2025, the Reporting Persons held or had a right to receive an aggregate of 7,482,961 Ordinary Shares of the Issuer, which constitutes approximately 10.7% of the outstanding Ordinary Shares of the Issuer. Number of shares as to which each Reporting Person has: (i) sole power to vote or to direct the vote: See Item 7 on the cover pages hereto. (ii) shared power to vote or to direct the vote: See Item 8 on the cover pages hereto. (iii) sole power to dispose or to direct the disposition of: See Item 9 on the cover pages hereto. (iv) shared power to dispose or to direct the disposition of: See Item 10 on the cover pages hereto. Mr. Kolatch as a principal of Jasper Lake may be deemed to exercise voting and investment power over the Ordinary Shares directly held by Jasper Lake (including Ordinary Shares into which the Note may be converted). Mr. Kolatch disclaims beneficial ownership over all securities beneficially owned by Jasper Lake, other than for the purpose of determining obligations under the Exchange Act, and the filing of this Amendment shall not be deemed an admission that Mr. Kolatch is the beneficial owner of such securities for any other purpose.
    (c)
    No transactions in the Ordinary Shares or securities convertible into, exercisable for, or exchangeable for Ordinary Shares were effected during the past sixty days by the Reporting Persons.
    (d)
    Except as otherwise described in this Item 5, no one other than the Reporting Persons has the right to receive, or the power to direct the receipt of, dividends from, or the proceeds from the sale of, any of the Ordinary Shares beneficially owned by the Reporting Persons as described in this Item 5.
    (e)
    Not applicable.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Jasper Lake Ventures One LLC
     
    Signature:/s/ Noah Kolatch
    Name/Title:Noah Kolatch, Authorized Signatory
    Date:09/30/2025
     
    Noah Kolatch
     
    Signature:/s/ Noah Kolatch
    Name/Title:NOAH KOLATCH
    Date:09/30/2025
    Get the next $BIOX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BIOX

    DatePrice TargetRatingAnalyst
    9/10/2025$2.50Buy → Hold
    Canaccord Genuity
    7/19/2024$17.00Buy
    Canaccord Genuity
    7/2/2024$15.00Buy
    ROTH MKM
    4/6/2023$15.00Outperform
    Oppenheimer
    9/30/2022$22.50Buy
    Canaccord Genuity
    10/8/2021$21.00Buy
    ROTH Capital
    More analyst ratings

    $BIOX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Bioceres downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Bioceres from Buy to Hold and set a new price target of $2.50

    9/10/25 7:58:04 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Canaccord Genuity resumed coverage on Bioceres with a new price target

    Canaccord Genuity resumed coverage of Bioceres with a rating of Buy and set a new price target of $17.00

    7/19/24 8:32:10 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    ROTH MKM resumed coverage on Bioceres with a new price target

    ROTH MKM resumed coverage of Bioceres with a rating of Buy and set a new price target of $15.00

    7/2/24 8:01:46 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    $BIOX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Bioceres Crop Solutions and Colorado Wheat Research Foundation Partner to Advance Climate-Resilient HB4® Wheat in the U.S.

    Bioceres Crop Solutions Corp. (NASDAQ:BIOX) and the Colorado Wheat Research Foundation (CWRF) today announced a strategic collaboration to jointly develop and commercialize HB4® wheat in the United States. The agreement combines Bioceres' proprietary HB4® technology, with CWRF's leadership in U.S. wheat innovation to create a next generation wheat production system. This system is designed to integrate climate resilience and environmentally responsible weed management, delivering greater productivity for growers and improved supply stability for customers. As part of the collaboration, Bioceres will grant CWRF exclusive, sublicensable rights to the HB4® trait in the U.S. territory. CWRF

    9/23/25 7:00:00 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2025 Financial and Operational Results

    Total revenues were $74.7 million in 4Q25 and $335.3 million in FY25 FY25 results reflect challenging year amid ag sector headwinds and macro pressures in Argentina Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal fourth quarter ended June 30, 2025. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted.

    9/9/25 6:00:00 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Bioceres Crop Solutions to Host Fiscal Fourth Quarter and Full Year 2025 Financial Results Conference Call on Tuesday, September 9, 2025 at 8:30 a.m. Eastern Time

    Bioceres Crop Solutions Corp. (NASDAQ:BIOX) ("Bioceres" or the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Tuesday, September 9, 2025 at 8:30 a.m. Eastern Time to discuss its results for the fiscal fourth quarter and full year ended June 30, 2025. A press release detailing these results will be issued prior to the call. Bioceres Chairman & Chief Executive Officer Federico Trucco and Head of Investor Relations Paula Savanti will host the conference call, followed by a question-and-answer session. The conference call w

    9/2/25 4:30:00 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    $BIOX
    SEC Filings

    View All

    SEC Form 6-K filed by Bioceres Crop Solutions Corp.

    6-K - Bioceres Crop Solutions Corp. (0001769484) (Filer)

    10/10/25 4:01:36 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    SEC Form 6-K filed by Bioceres Crop Solutions Corp.

    6-K - Bioceres Crop Solutions Corp. (0001769484) (Filer)

    10/2/25 6:05:15 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Amendment: SEC Form SCHEDULE 13D/A filed by Bioceres Crop Solutions Corp.

    SCHEDULE 13D/A - Bioceres Crop Solutions Corp. (0001769484) (Subject)

    10/1/25 6:05:27 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    $BIOX
    Financials

    Live finance-specific insights

    View All

    Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2025 Financial and Operational Results

    Total revenues were $74.7 million in 4Q25 and $335.3 million in FY25 FY25 results reflect challenging year amid ag sector headwinds and macro pressures in Argentina Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal fourth quarter ended June 30, 2025. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted.

    9/9/25 6:00:00 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Bioceres Crop Solutions to Host Fiscal Fourth Quarter and Full Year 2025 Financial Results Conference Call on Tuesday, September 9, 2025 at 8:30 a.m. Eastern Time

    Bioceres Crop Solutions Corp. (NASDAQ:BIOX) ("Bioceres" or the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Tuesday, September 9, 2025 at 8:30 a.m. Eastern Time to discuss its results for the fiscal fourth quarter and full year ended June 30, 2025. A press release detailing these results will be issued prior to the call. Bioceres Chairman & Chief Executive Officer Federico Trucco and Head of Investor Relations Paula Savanti will host the conference call, followed by a question-and-answer session. The conference call w

    9/2/25 4:30:00 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Bioceres Crop Solutions Reports Fiscal Third Quarter 2025 Financial and Operational Results

    Total revenues in 3Q25 were $60.6 million 3Q25 net loss was $1.6 million and Adjusted EBITDA1 was $9.0 million Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal third quarter ended March 31, 2025. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted. Financial & Business Highlights Total revenues were $60

    5/21/25 7:01:00 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    $BIOX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Bioceres Crop Solutions Corp.

    SC 13G - Bioceres Crop Solutions Corp. (0001769484) (Subject)

    10/23/24 2:32:38 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Amendment: SEC Form SC 13D/A filed by Bioceres Crop Solutions Corp.

    SC 13D/A - Bioceres Crop Solutions Corp. (0001769484) (Subject)

    9/20/24 9:09:41 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    SEC Form SC 13D/A filed by Bioceres Crop Solutions Corp. (Amendment)

    SC 13D/A - Bioceres Crop Solutions Corp. (0001769484) (Subject)

    3/25/24 8:58:35 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials